Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;83(1):197-199.
doi: 10.1016/j.jaad.2020.03.050. Epub 2020 Mar 27.

Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients

Maria L Espinosa  1 , Morgan T Nguyen  1 , Amaia Saenz Aguirre  1 , Maria Estela Martinez-Escala  1 , Jane Kim  1 , Christina J Walker  1 , David S Pontes  1 , Jonathan I Silverberg  2 , Jaehyuk Choi  3 , Barbara Pro  4 , Laura B Pincus  5 , Joan Guitart  1 , Xiaolong A Zhou  6
Affiliations

Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients

Maria L Espinosa et al. J Am Acad Dermatol. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None declared.

Comment in

  • Dupilumab and cutaneous T-cell lymphoma.
    Elston DM. Elston DM. J Am Acad Dermatol. 2020 Jul;83(1):33-34. doi: 10.1016/j.jaad.2020.03.051. Epub 2020 Mar 27. J Am Acad Dermatol. 2020. PMID: 32229280 No abstract available.
  • Dupilumab cuts both ways.
    Heymann WR. Heymann WR. J Am Acad Dermatol. 2020 Jul;83(1):35-36. doi: 10.1016/j.jaad.2020.05.010. Epub 2020 May 11. J Am Acad Dermatol. 2020. PMID: 32437719 No abstract available.

References

    1. Gooderham MJ, Hong HC-h, Eshtiaghi P, Papp KA. Dupilumab: A review of its use in the treatment of atopic dermatitis. Journal of the American Academy of Dermatology 2018;78:S28–S36. - PubMed
    1. Saulite I, Hoetzenecker W, Weidinger S, Cozzio A, Guenova E, Wehkamp U. Sezary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets. Biomed Res Int 2016;2016:9717530. - PMC - PubMed
    1. Serrano L, Martinez-Escala ME, Zhou XA, Guitart J. Pruritus in Cutaneous T-Cell Lymphoma and Its Management. Dermatologic Clinics 2018;36:245–58. - PubMed
    1. Guttman-Yassky E, Bissonnette R, Ungar B, Suarez-Farinas M, Ardeleanu M, Esaki H et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol 2019;143:155–72. - PubMed
    1. Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov IV, Iversen L et al. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover. Seminars in immunopathology 2017;39:269–82. - PMC - PubMed

Substances